A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
INVAC-1 Anti-Cancer hTERT DNA Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types
- Status
- COMPLETED
- Phase
- PHASE1
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
- Status
- COMPLETED
- Phase
- PHASE1
First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Oral ONC201 in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer
- Status
- WITHDRAWN
- Phase
- PHASE1
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
- Status
- UNKNOWN
- Phase
- N/A
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1